Zydus Lifesciences Limited (ZYDUSLIFE) — Strategic Asset Allocation Index
Zydus Lifesciences Limited (ZYDUSLIFE) has a Strategic Asset Allocation Index of 35.8% as of September 2022. Strategic assets (PP&E of Rs67.22 Billion plus long-term investments of Rs-) total Rs67.22 Billion, measured against net assets of Rs187.68 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. Check ZYDUSLIFE asset liquidity ratio to evaluate the company's liquid asset resilience ratio.
SAAI
Strategic Assets
PP&E
Net Assets
Zydus Lifesciences Limited Strategic Asset Allocation Index (2020–2022)
This chart shows how Zydus Lifesciences Limited's Strategic Asset Allocation Index has evolved across 3 annual periods from 2020 to 2022. As of September 2022, the index stands at 35.8%, representing strategic assets of Rs67.22 Billion against net assets of Rs187.68 Billion INR. See Zydus Lifesciences Limited (ZYDUSLIFE) flexibility index to measure the company's free cash flow as a share of total liabilities.
Annual Strategic Asset Allocation Index for Zydus Lifesciences Limited (2020–2022)
The table below presents the year-by-year Strategic Asset Allocation Index for Zydus Lifesciences Limited from 2020 to 2022, covering 3 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see Zydus Lifesciences Limited (ZYDUSLIFE) total market value.
| Year | SAAI | Strategic Assets (INR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 33.7% | Rs64.23 Billion | Rs64.23 Billion | Rs- | Rs190.54 Billion | ▼ -8.7 pp |
| 2021 | 42.4% | Rs63.33 Billion | Rs63.33 Billion | Rs- | Rs149.30 Billion | ▼ -10.5 pp |
| 2020 | 52.9% | Rs61.94 Billion | Rs61.94 Billion | Rs- | Rs117.10 Billion | — |